全文获取类型
收费全文 | 2680篇 |
免费 | 157篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 140篇 |
妇产科学 | 52篇 |
基础医学 | 239篇 |
口腔科学 | 27篇 |
临床医学 | 201篇 |
内科学 | 636篇 |
皮肤病学 | 44篇 |
神经病学 | 150篇 |
特种医学 | 179篇 |
外科学 | 442篇 |
综合类 | 35篇 |
预防医学 | 107篇 |
眼科学 | 121篇 |
药学 | 142篇 |
中国医学 | 4篇 |
肿瘤学 | 276篇 |
出版年
2023年 | 17篇 |
2022年 | 40篇 |
2021年 | 104篇 |
2020年 | 50篇 |
2019年 | 89篇 |
2018年 | 109篇 |
2017年 | 54篇 |
2016年 | 67篇 |
2015年 | 75篇 |
2014年 | 120篇 |
2013年 | 135篇 |
2012年 | 185篇 |
2011年 | 172篇 |
2010年 | 95篇 |
2009年 | 106篇 |
2008年 | 159篇 |
2007年 | 143篇 |
2006年 | 111篇 |
2005年 | 103篇 |
2004年 | 83篇 |
2003年 | 64篇 |
2002年 | 54篇 |
2001年 | 45篇 |
2000年 | 39篇 |
1999年 | 52篇 |
1998年 | 40篇 |
1997年 | 45篇 |
1996年 | 40篇 |
1995年 | 27篇 |
1994年 | 28篇 |
1993年 | 23篇 |
1992年 | 32篇 |
1991年 | 30篇 |
1990年 | 32篇 |
1989年 | 42篇 |
1988年 | 39篇 |
1987年 | 31篇 |
1986年 | 19篇 |
1985年 | 24篇 |
1984年 | 10篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1980年 | 11篇 |
1977年 | 8篇 |
1976年 | 12篇 |
1974年 | 6篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1970年 | 8篇 |
1968年 | 6篇 |
排序方式: 共有2858条查询结果,搜索用时 15 毫秒
41.
Sonal A. Parikh B.S. Scott A. Davis M.A. Daniel P. Krowchuk M.D. Steven R. Feldman M.D. Ph.D. 《Pediatric dermatology》2014,31(5):551-555
Acne is occurring more frequently in younger age groups, but most available treatments are considered off‐label in young children. As the epidemiology of acne has changed to include younger children over the past 20 years, neither regulators, pharmaceutical companies, nor clinicians have understood the need or value of obtaining regulatory sanctions for problems physicians have managed using clinical judgment. The objective of this study was to analyze the frequency of off‐label acne treatment according to age and other demographic factors. We searched the National Ambulatory Medical Care Survey from 1993 to 2010 for visits in children younger than 12 years of age for the diagnosis of International Classification of Diseases, Ninth Revision, code 706.1. We tabulated leading acne treatments and assessed factors associated with off‐label prescribing. Off‐label but appropriate acne treatments were used in 29% of acne visits for children younger than 12 years of age. Dermatologists were more likely than pediatricians to prescribe off‐label treatment (p < 0.001). The most frequently used off‐label treatments were topical retinoids, followed by oral antibiotics. There was no significant trend in the rate of off‐label prescribing over time (p = 0.40). Off‐label treatment is well within the standard of care for young children with acne. More data on the use of topical retinoids in young children will improve our understanding of their use, which may help optimize treatment outcomes for children with acne. 相似文献
42.
Martial L. Ndeffo Mbah Sunil Parikh Alison P. Galvani 《The American journal of tropical medicine and hygiene》2015,92(3):555-560
Artemisinin-based combination therapies (ACTs) are currently considered the first-line treatments for uncomplicated Plasmodium falciparum malaria. Among these, artemether-lumefantrine (AL) has been the most widely prescribed ACT in sub-Saharan Africa. Recent clinical trials conducted in sub-Saharan Africa have shown that dihydroartemisinin-piperaquine (DP), a most recent ACT, may have a longer post-treatment prophylactic period and post-treatment infection period (duration of gametocyte carriage) than AL. Using epidemiological and clinical data on the efficacy of AL and DP, we developed and parameterized a mathematical transmission model that we used to compare the population-level impact of AL and DP for reducing P. falciparum malaria transmission in sub-Saharan Africa. Our results showed that DP is likely to more effectively reduce malaria incidence of clinical episodes than AL. However in low P. falciparum transmission areas, DP and AL are likely to be equally effective in reducing malaria prevalence. The predictions of our model were shown to be robust to the empirical uncertainty summarizing the epidemiological parameters. DP should be considered as a replacement for AL as first-line treatment of uncomplicated malaria in highly endemic P. falciparum communities. To optimize the effectiveness of ACTs, it is necessary to tailor treatment policies to the transmission intensity in different settings. 相似文献
43.
44.
45.
46.
Jonathan G. Amatruda MD Ronit Katz DPhil Carmen A. Peralta MD MAS Michelle M. Estrella MD MHS Harini Sarathy MBBS MHS Linda F. Fried MD MPH Anne B. Newman MD MPH Chirag R. Parikh MBBS PhD Joachim H. Ix MD MAS Mark J. Sarnak MD MS Michael G. Shlipak MD MPH for the Health ABC Study 《Journal of the American Geriatrics Society》2021,69(3):726-734
47.
Raad Mohamad Gorgis Sarah Abshire Chelsea Yost Monica Dabbagh Mohammed F Chehab Omar Aurora Lindsey Patel Sati Nona Paul Yan Jerry Singh Gurjit Syrjamaki John Kaatz Scott Parikh Sachin 《Journal of thrombosis and thrombolysis》2022,53(3):567-575
Journal of Thrombosis and Thrombolysis - Although certain risk factors have been associated with morbidity and mortality, validated emergency department (ED) derived risk prediction models specific... 相似文献
48.
背景目前已开展了对重性精神病患者进提供连续性服务的研究。目的探讨基层对有抑郁症风险患者提供连续性服务的水平,并与对心力衰竭患者的服务水平进行对比。方法采用抑郁症风险患者与心力衰竭患者对比的探索性研究。采用患者问卷评估服务的持续性,包含如下内容:(1)联系的服务提供者数(个人连续性);(2)诊所内服务提供者之间的合作(团队连续性)(6个项目,分数1~5分);(3)诊所外全科医师与服务提供者之间的合作(跨界连续性)(4个项目,分数1~5分)。结果大多数抑郁症风险患者在过去1年中寻遍整个服务提供界联系了几个服务提供者,曾遇到过高水平团队连续性服务及低水平跨界连续性服务。在诊所中可接触到的不同服务提供者要明显多于心力衰竭患者服务提供者(P<0.01)。抑郁症风险患者的服务提供者之间的合作更好一些,每项平均得分4.3分,心力衰竭患者得分为4.0分(P=0.03)。然而,跨界连续性服务方面正好相反:抑郁症风险患者每项平均得分3.5分,心力衰竭患者得分为4.0分(P=0.01)。结论抑郁症风险患者与心力衰竭患者之间的探索性对比显示:体验服务连续性方面的差距不大。对此还应行进一步分析。 相似文献
49.
Novel Use of Ultrasound to Teach Reproductive System Physical Examination Skills and Pelvic Anatomy
下载免费PDF全文
![点击此处可从《Journal of ultrasound in medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
50.